The MPS received a request for feedback from the Maryland Department of Health (MDH) regarding the Prescription Drug Monitoring Program (PDMP) Use Mandate.  The law requires that the MDH must determine:

(1) the technical capabilities of the PDMP are sufficient; and

(2) the use mandate is important to protect public health and promote good patient care

MDH provided reports supporting both of these points.  The MPS solicited member input through the listserv and crafted a letter outlining concerns about the impact of this mandate on prescribers as well as patients.  More clarification, support, resources and education were among the recommendations.  Click here to view the details.